This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Stocks Under $10 Loved by the Bulls


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Sequenom (SQNM) is a molecular diagnostic testing and genetics analysis company committed to providing molecular diagnostic testing services, and research use only products, services, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research. This stock is trading up 10% to $4.10 in recent trading.

Today's Range: $3.84-$4.19

52-Week Range: $3.46-$8.01

Volume: 3.55 million

Three-Month Average Volume: 3.6 million

Shares of SQNM are ripping higher today after Maxim Group started coverage on the stock with a buy rating and a $6 price target.

>>Hot Biotech Stocks Traded by Hedge Funds

From a technical perspective, SQNM is skyrocketing higher here with decent volume, and this move has pushed the stock into near-term breakout territory since it's cleared some overhead resistance at $3.85.

Traders should now look for long-biased trades once SQNM triggers its next major breakout. That breakout will hit once SQNM takes out $4.20 and then both its 50-day at $4.43 and its 200-day at $4.49 with high-volume. Look for a sustained move or close above those levels with volume that's near or above 3.6 million shares. If we get that action soon, then look for SQNM to hit its next significant overhead resistance levels at $5.20 to $5.44 in the near future.
2 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
AAPL $92.91 -1.40%
FB $99.63 -1.40%
GOOG $671.94 -1.80%
TSLA $153.53 6.90%
YHOO $26.57 -2.00%


Chart of I:DJI
DOW 15,560.85 -353.89 -2.22%
S&P 500 1,819.97 -31.89 -1.72%
NASDAQ 4,234.2370 -49.3550 -1.15%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs